Profile | GDS4284 / 228006_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 3307.83 | 89 |
GSM687648 | Patient 402 control | 4478.45 | 92 |
GSM687653 | Patient 403 control | 3720.94 | 91 |
GSM687658 | Patient 404 control | 4643.57 | 93 |
GSM687663 | Patient 411 control | 4200.6 | 92 |
GSM687668 | Patient 422 control | 3924.94 | 91 |
GSM687673 | Patient 424 control | 4768.67 | 93 |
GSM687678 | Patient 425 control | 4656.69 | 93 |
GSM687683 | Patient 427 control | 4247.04 | 92 |
GSM687688 | Patient 428 control | 3248.9 | 90 |
GSM687695 | Patient 441 control | 8664.26 | 96 |
GSM687699 | Patient 443 control | 3546.48 | 91 |
GSM687704 | Patient 444 control | 2892.7 | 88 |
GSM687707 | Patient 448 control | 3880.45 | 91 |
GSM687712 | Patient 449 control | 3327.5 | 90 |
GSM687719 | Patient 450 control | 4688.03 | 93 |
GSM687724 | Patient 451 control | 4404.57 | 92 |
GSM687728 | Patient 452 control | 6852.57 | 95 |
GSM687646 | Patient 401 treated 24h | 3685.07 | 91 |
GSM687649 | Patient 402 treated 24h | 4217.09 | 92 |
GSM687665 | Patient 411 treated 24h | 4712.35 | 93 |
GSM687651 | Patient 402 treated 4 weeks | 4188.26 | 92 |
GSM687667 | Patient 411 treated 4 weeks | 3603.24 | 91 |
GSM687670 | Patient 422 treated 24h | 3693.61 | 91 |
GSM687671 | Patient 422 treated 4 weeks | 3800.09 | 91 |
GSM687654 | Patient 403 treated 24h | 3651.43 | 91 |
GSM687675 | Patient 424 treated 24h | 4563.21 | 93 |
GSM687685 | Patient 427 treated 24h | 4867.58 | 93 |
GSM687656 | Patient 403 treated 4 weeks | 3728.7 | 91 |
GSM687677 | Patient 424 treated 4 weeks | 4315.45 | 92 |
GSM687687 | Patient 427 treated 4 weeks | 3998.1 | 91 |
GSM687692 | Patient 428 treated 4h | 4407.27 | 92 |
GSM687716 | Patient 449 treated 4h | 2832.28 | 88 |
GSM687722 | Patient 450 treated 4h | 4948.94 | 93 |
GSM687680 | Patient 425 treated 24h | 5187.15 | 94 |
GSM687690 | Patient 428 treated 24h | 4977.64 | 93 |
GSM687700 | Patient 443 treated 24h | 6490.9 | 95 |
GSM687705 | Patient 444 treated 24h | 3243.97 | 89 |
GSM687714 | Patient 449 treated 24h | 3542.15 | 90 |
GSM687721 | Patient 450 treated 24h | 5118.37 | 94 |
GSM687682 | Patient 425 treated 4 weeks | 5197.08 | 94 |
GSM687694 | Patient 428 treated 4 weeks | 3792.74 | 91 |
GSM687702 | Patient 443 treated 4 weeks | 5157.22 | 94 |
GSM687718 | Patient 449 treated 4 weeks | 2969.66 | 89 |
GSM687723 | Patient 450 treated 4 weeks | 4207.43 | 92 |
GSM687661 | Patient 404 treated 4h | 4302.12 | 92 |
GSM687710 | Patient 448 treated 4h | 4006.2 | 91 |
GSM687726 | Patient 451 treated 4h | 4541.49 | 93 |
GSM687730 | Patient 452 treated 4h | 5495.91 | 95 |
GSM687660 | Patient 404 treated 24h | 19548.1 | 98 |
GSM687697 | Patient 441 treated 24h | 8305.15 | 96 |
GSM687709 | Patient 448 treated 24h | 3057.29 | 89 |
GSM687725 | Patient 451 treated 24h | 5192.85 | 94 |
GSM687729 | Patient 452 treated 24h | 14705.7 | 98 |
GSM687727 | Patient 451 treated 4 weeks | 4338.88 | 92 |
GSM687731 | Patient 452 treated 4 weeks | 5093.34 | 94 |